Literature DB >> 468068

Chronic oral arsenic intoxication as a possible aetiological factor in idiopathic portal hypertension (non-cirrhotic portal fibrosis) in India.

D V Datta, S K Mitra, P N Chhuttani, R N Chakravarti.   

Abstract

Estimates were made of the arsenic concentration in liver specimens from nine patients having idiopathic portal hypertension (IP), and in four livers these were found to be significantly higher than those in patients with cirrhosis and in control subjects. The splenovenogram revealed extensive portosystemic collateral circulation. Corrected sinusoidal pressure and blood flow studies showed higher levels in four patients than in normal subjects. Microscopic examination of liver tissues revealed periportal fibrosis. The higher hepatic arsenic levels that were found were due to the inadvertent drinking of water contaminated with arsenic, adulterated opium, and indigenous medicines. A history of opium intake was not forthcoming but two patients had drunk water contaminated with arsenic and two others had taken bhasams (Ayurvedic medicines prepared by repeated oxidation of ores). Though the aetiology of idiopathic portal hypertension is not known, it is possible that arsenic intake may be one of the factors.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 468068      PMCID: PMC1412437          DOI: 10.1136/gut.20.5.378

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  18 in total

1.  The use of indocyanine green in the measurement of hepatic blood flow and as a test of hepatic function.

Authors:  J CAESAR; S SHALDON; L CHIANDUSSI; L GUEVARA; S SHERLOCK
Journal:  Clin Sci       Date:  1961-08       Impact factor: 6.124

2.  Arsenic content of drinking water in villages in Northern India. A concept of arsenicosis.

Authors:  D V Datta; M K Kaul
Journal:  J Assoc Physicians India       Date:  1976-09

3.  Cirrhosis of the liver in northern India. A clinicopathologic study.

Authors:  V RAMALINGASWAMI; K L WIG; S K SAMA
Journal:  Arch Intern Med       Date:  1962-09

4.  Fowler's solution as an etiologic agent in cirrhosis.

Authors:  M FRANKLIN; W B BEAN; R C HARDIN
Journal:  Am J Med Sci       Date:  1950-06       Impact factor: 2.378

5.  Arsenic adulteration in opium. (Arsenicosis--a real danger to health in developing countries).

Authors:  D V Datta; M K Kaul
Journal:  Bull Narc       Date:  1977 Jul-Sep

Review 6.  Non-cirrhotic portal fibrosis ('idiopathic' portal hypertension in India).

Authors:  D V Datta
Journal:  J Assoc Physicians India       Date:  1976-08

7.  Malarial antibody studies in non-cirrhotic portal fibrosis-a preliminary observation.

Authors:  R C Mahajan; D V Dutta
Journal:  Indian J Med Res       Date:  1976-05       Impact factor: 2.375

8.  Arsenic in opium.

Authors:  D V Datta
Journal:  Lancet       Date:  1977-02-26       Impact factor: 79.321

9.  Idiopathic portal hypertension.

Authors:  J P Villeneuve; P M Huet; J G Joly; D Marleau; J Côté; A Légaré; M Lafortune; P Lavoie; A Viallet
Journal:  Am J Med       Date:  1976-10       Impact factor: 4.965

10.  Arsenical neuropathy.

Authors:  P N Chhuttani; L S Chawla; T D Sharma
Journal:  Neurology       Date:  1967-03       Impact factor: 9.910

View more
  17 in total

Review 1.  Non-cirrhotic portal fibrosis.

Authors:  S K Sarin
Journal:  Gut       Date:  1989-03       Impact factor: 23.059

2.  Study on arsenic level in public water supply of Delhi using hydride generator accessory coupled with atomic absorption spectrophotometer.

Authors:  Sanjeev Lalwani; T D Dogra; D N Bhardwaj; R K Sharma; O P Murty
Journal:  Indian J Clin Biochem       Date:  2006-03

3.  Noncirrhotic intrahepatic portal hypertension: towards a unifying definition and etiology.

Authors:  B S Ramakrishna
Journal:  Indian J Gastroenterol       Date:  2014-05-31

Review 4.  Idiopathic Non-Cirrhotic Intrahepatic Portal Hypertension (NCIPH)-Newer Insights into Pathogenesis and Emerging Newer Treatment Options.

Authors:  Ashish Goel; Joshua E Elias; Chundamannil E Eapen; Banumathi Ramakrishna; Elwyn Elias
Journal:  J Clin Exp Hepatol       Date:  2014-07-28

Review 5.  Extra hepatic portal venous obstruction.

Authors:  D R Triger
Journal:  Gut       Date:  1987-10       Impact factor: 23.059

6.  Long term consequences of arsenical treatment for multiple sclerosis.

Authors:  D A Robertson; T S Low-Beer
Journal:  Br Med J (Clin Res Ed)       Date:  1983-02-19

7.  Indian childhood cirrhosis.

Authors: 
Journal:  Br Med J (Clin Res Ed)       Date:  1981-11-21

8.  Noncirrhotic portal fibrosis/idiopathic portal hypertension: APASL recommendations for diagnosis and treatment.

Authors:  Shiv Kumar Sarin; Ashish Kumar; Yogesh Kumar Chawla; Sanjay Saran Baijal; Radha Krishna Dhiman; Wasim Jafri; Laurentius A Lesmana; Debendranath Guha Mazumder; Masao Omata; Huma Qureshi; Rizvi Moattar Raza; Peush Sahni; Puja Sakhuja; Mohammad Salih; Amal Santra; Barjesh Chander Sharma; Praveen Sharma; Gamal Shiha; Jose Sollano
Journal:  Hepatol Int       Date:  2007-09-11       Impact factor: 6.047

9.  Chronic arsenic toxicity from drinking tubewell water in rural West Bengal.

Authors:  D N Guha Mazumder; A K Chakraborty; A Ghose; J D Gupta; D P Chakraborty; S B Dey; N Chattopadhyay
Journal:  Bull World Health Organ       Date:  1988       Impact factor: 9.408

Review 10.  Liver is a target of arsenic carcinogenesis.

Authors:  Jie Liu; Michael P Waalkes
Journal:  Toxicol Sci       Date:  2008-06-19       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.